Phenotype of TP53 and influence on outcome after allogeneic stem cell transplantation for myelofibrosis

被引：0
|
作者：
Gagelmann, N. [1 ]
Badbaran, A. [1 ]
Panagiota, V [2 ]
Thol, F. [2 ]
Heuser, M. [2 ]
Wolschke, C. [1 ]
Schroeder, T. [3 ]
Rautenberg, C. [3 ]
Reinhardt, H. C. [3 ]
Cassinat, B. [4 ]
Robin, M. [4 ]
Scott, B. L. [5 ]
Kroeger, N. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany
[2] Hannover Med Sch, Hannover, Germany
[3] Univ Klinikum Essen, Essen, Germany
[4] Hop St Louis, APHP, Paris, France
[5] Fred Hutchinson Canc Res Ctr, Seattle, WA USA
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V295
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [31] Allogeneic hematopoietic stem cell transplantation for myelofibrosis
    Deeg, HJ
    Gooley, TA
    Flowers, MED
    Sale, GE
    Slattery, JT
    Anasetti, C
    Chauncey, TR
    Doney, K
    Georges, GE
    Kiem, HP
    Martin, PJ
    Petersdorf, EW
    Radich, J
    Sanders, JE
    Sandmaier, BM
    Warren, EH
    Witherspoon, RP
    Storb, R
    Appelbaum, FR
    BLOOD, 2003, 102 (12) : 3912 - 3918
  • [32] Allogeneic hematopoietic stem cell transplantation for myelofibrosis
    Barosi, Giovanni
    Bacigalupo, Andrea
    CURRENT OPINION IN HEMATOLOGY, 2006, 13 (02) : 74 - 78
  • [33] Improving allogeneic stem cell transplantation in myelofibrosis
    Nico Gagelmann
    Nicolaus Kröger
    International Journal of Hematology, 2022, 115 : 619 - 625
  • [34] Allogeneic Stem Cell Transplantation for Myelofibrosis in 2012
    McLornan, Donal P.
    Mead, Adam J.
    Jackson, Graham
    Harrison, Claire N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (04) : 413 - 425
  • [35] Improving allogeneic stem cell transplantation in myelofibrosis
    Gagelmann, Nico
    Kroeger, Nicolaus
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (05) : 619 - 625
  • [36] Allogeneic stem cell transplantation as treatment for myelofibrosis
    S G Papageorgiou
    A Castleton
    A Bloor
    P D Kottaridis
    Bone Marrow Transplantation, 2006, 38 : 721 - 727
  • [37] QUALITY OF LIFE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELOFIBROSIS
    Machate, N.
    Alchalby, H.
    Zabelina, T.
    Wulf, G.
    Sehner, S.
    Wolff, D.
    Kobbe, G.
    Bornhaeuser, M.
    Baurmann, H.
    Bethge, W.
    Zander, A.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S31 - S32
  • [38] Incidence of late Relapse after Allogeneic Stem Cell Transplantation for Myelofibrosis
    Atagunduz, Isik Kaygusuz
    Badbaran, Anita
    Zeck, Gaby
    Wolschke, Christine
    Ayuk, Francis
    Christopeit, Maximilian
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 274 - 274
  • [39] Favorable outcome of allogeneic stem cell transplantation in myelofibrosis harboring MPL mutation
    Mannina, Daniele
    Gagelmann, Nico
    Ditschkowski, Markus
    Bogdanov, Rashit
    Bredin, Swan
    Robin, Marie
    Cassinat, Bruno
    Shahswar, Rabia
    Thol, Felicitas
    Heuser, Michael
    Beelen, Dietrich
    Badbaran, Anita
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2019, 54 : 51 - 52
  • [40] TP53 mutations and polymorphisms in primary myelofibrosis
    Raza, Sania
    Viswanatha, David
    Frederick, Lori
    Lasho, Terra
    Finke, Christy
    Knudson, Ryan
    Ketterling, Rhett
    Pardanani, Animesh
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (02) : 204 - 206
12345